These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. PXS-4681A, a potent and selective mechanism-based inhibitor of SSAO/VAP-1 with anti-inflammatory effects in vivo. Foot JS, Yow TT, Schilter H, Buson A, Deodhar M, Findlay AD, Guo L, McDonald IA, Turner CI, Zhou W, Jarolimek W. J Pharmacol Exp Ther; 2013 Nov; 347(2):365-74. PubMed ID: 23943052 [Abstract] [Full Text] [Related]
5. SSAO inhibitors suppress hepatocellular tumor growth in mice. Li R, Li H, Luo HJ, Lin ZX, Jiang ZW, Luo WH. Cell Immunol; 2013 Nov; 283(1-2):61-9. PubMed ID: 23850964 [Abstract] [Full Text] [Related]
6. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition. Carpéné C, Bizou M, Tréguer K, Hasnaoui M, Grès S. J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340 [Abstract] [Full Text] [Related]
7. Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema. Inoue T, Morita M, Tojo T, Yoshihara K, Nagashima A, Moritomo A, Ohkubo M, Miyake H. Bioorg Med Chem; 2013 Mar 01; 21(5):1219-33. PubMed ID: 23337801 [Abstract] [Full Text] [Related]
12. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications. Stolen CM, Madanat R, Marti L, Kari S, Yegutkin GG, Sariola H, Zorzano A, Jalkanen S. FASEB J; 2004 Apr 01; 18(6):702-4. PubMed ID: 14977883 [Abstract] [Full Text] [Related]
13. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues. Kinemuchi H, Sugimoto H, Obata T, Satoh N, Ueda S. Neurotoxicology; 2004 Jan 01; 25(1-2):325-35. PubMed ID: 14697907 [Abstract] [Full Text] [Related]
14. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking. Yraola F, García-Vicente S, Fernandez-Recio J, Albericio F, Zorzano A, Marti L, Royo M. J Med Chem; 2006 Oct 19; 49(21):6197-208. PubMed ID: 17034126 [Abstract] [Full Text] [Related]
15. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia. Sun P, Solé M, Unzeta M. Cerebrovasc Dis; 2014 Oct 19; 37(3):171-80. PubMed ID: 24503888 [Abstract] [Full Text] [Related]
16. Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study. Emanuela B, Minarini A, Tumiatti V, Milelli A, Lunelli M, Pegoraro M, Rizzoli V, Di Paolo ML. Amino Acids; 2012 Feb 19; 42(2-3):913-28. PubMed ID: 21858471 [Abstract] [Full Text] [Related]
17. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity. Wang EY, Gao H, Salter-Cid L, Zhang J, Huang L, Podar EM, Miller A, Zhao J, O'rourke A, Linnik MD. J Med Chem; 2006 Apr 06; 49(7):2166-73. PubMed ID: 16570912 [Abstract] [Full Text] [Related]